Tag Archives | gene therapy

Mid-Cap Biotechs Lead the Market: Pre-ASCO Scoreboard…Updates 6/4/18

go to link 6/4/18…after close Update-2…IBB down 0.65%, XBI down 0.22%.  Momentum Waning Big Winners Today : BLUE, FMI, GHDX, IMMU, MRK It would appear that biotech stocks need to be bought prior to ASCO as has been then trend in the past i.e sell before the news. However there will be some clear cut winners after the Meeting. […]

Continue Reading 0

Financial and Political Crisis in Italy Disrupts Biotech Stock Momentum…Updates with rally today 5/30

follow link Updates 5/30 Pre-ASCO Rally: XBI regains momentum to $94 level. IBB breaks through SMA 200 level to $108+. Many mid-caps from our watch list soaring-CRSP*, FMI, FOLD, LGND, LOXO, NKTR, SGEN, SRPT etc. *Note CRSP got whacked after hours down 13 points! The FDA has put the clinical trial for sickle cell treatment on hold. […]

Continue Reading 0

Biotechs Soar After Big Trump Drug Price Speech- Mid-Caps Should Outperform…Updates

enter site Update: 5/17…Mini-Rally Continues With Help From ASCO Abstracts XBI hits $93.78 above April highs, up 5.32% over 5 days, 10.5% YTD. IBB at April highs at $107.59, up 3.62% over 5 days, up 0.77% YTD Many Mid-Caps are hot: BLUE, CRSP, EXEL, FOLD, LGND, LOXO. See our list below. Gene editing stocks move up: CLLS, […]

Continue Reading 0

Biotechs Bounce From Support Levels Despite Mixed Earnings Reports…Update 5/3- Testing 2018 Lows

5/3 Testing February bottom and 200 MA of ~$100 on IBB and ~$85 on XBI. Red screen day. 2PM EDT Dow near flat line. Need to look for major gap up. Another potential negative on the horizon: “Bold Action on Drug Pricing” by Sect’y HHS. 5/2  Biotech Stocks Are About To Test 2018 Lows: It […]

Continue Reading 0

Biotech and Pharma Stocks Await Q1 Earnings But Gene Editing Stocks Sell-Off

75 mg benadryl Speculative Biotech Stocks Sell-Off in Profit Taking: Gene Editing Biotech stocks held current levels but small caps and speculative stocks sold off with the XBI down 1%. Most large caps were in the green with an upgrade from Goldman Sachs helping Merck (MRK) up 2.4% with a bullish story on Keytruda. Amgen (AMGN) offers good […]

Continue Reading 0

Biotechs Bounce off Bottom on Novartis Deal but Fades Later in the Day…Updates

Updates 4/11/18 Biotechs Holding Above Recent Bottom 4/6/18 FBT up 2.8% over 5 days, up 6% YTD XBI up 1.77% over 5 days, up 2.19% YTD IBB down 0.72% over 5 days, down 3.67% YTD Busted Biotechs Review In our “Busted Biotechs” article we said that the XBI trade at 83-84 would be good, now […]

Continue Reading 0

Rayno BioBeat #3…Biotech Bull Market Intact Despite Shaky Start… Update-1

4/2/18 12:30P Update Biotechs break through 2018 support levels with XBI now needs to hold December lows at $80. IBB at double bottom hit in November/December at $102 level. Watch Mid-Cap list below for sector weakness. ============== Biotech Bull Market Is Intact with Unusual Volatility Biotech Stocks Will Try to Regain Bullish Footing After A […]

Continue Reading 0

Market Rout: Biotechs Busted In Turmoil From Tariffs…Updates

Sell-Off Gets Scary–NASDAQ Futures Still Down at 1:30A EDT 3/28 Double Bottom -Double Top on XBI and Testing February Lows at $87 Another Sell-Off=Tuesday Movers 3/27/18 Large Caps % Up-NONE FBT Down 3.23%, IBB Down 2.77% to $105.12, QQQ down 3.24%, XBI down 4.27% Mid-caps % Up -None ========== BIG RALLY-Monday Movers 3/26/18 FBT Up 2.83%, […]

Continue Reading 0

Weak NASDAQ Leaves Biotech Stocks Stalled…Update-1

Update-1 …March 18- Market jittery on potential global trade war, rising interest rate concerns and political risk. Also Sales to U.S. retailers fell 0.1% in February a 3 month slide. Biotechs are in a risk-off mode with a weak tape. Dow down 0.47%, NASDAQ down 0.2%, IBB down 0.98%, XBI down 1.56% Biotechs stocks were red across […]

Continue Reading 0

Biotech is Hot Sparked By Biotech M&A Deals for Juno and Bioverativ…Update-1

Update-1 Jan 23, 2018… Biotech Breakout Rally Continues The biotech rally cruised on to the second day with the smaller cap, equal weighted XBI moving up 2% to $95.82 a 12 month high. The large cap weighted IBB followed up 1.12% to $116.81 also a 12 month high. The media especially CNBC trucked right along […]

Continue Reading 0